MAPT and dementia: Middle-aged human APOE4 carriers without dementia had higher BBB permeability in the MTL regions than non-carriers, which correlated with cognitive dysfunction and with a CSF vascular marker, soluble platelet-derived growth factor receptor-β (sPDGFRβ), independent of Aβ and tau (Nation et al., 2019).